At a glance
ClinicalIndex Comparison RecordN/ACompleted· 178 enrolled
Drug / intervention
CRT-D and LV lead (Quartet™ lead and Promote Q® device system)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
In Brief
A clinical study evaluating CRT-D and LV lead (Quartet™ lead and Promote Q® device system) for Heart Failure. Completed, enrolled 178 participants across 24 sites.
Detailed Summary
The objective of this study is to assess the safety and efficacy of the Quartet™ lead and Promote Q® device system in a patient population indicated for cardiac resynchronization therapy.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Failure
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartSep 2009
First PostedOct 2009
Primary CompletionSep 2010
Study CompletionJul 2012
TodayJul 2026
First PostedOct 7, 2009
Enrollment StartSep 1, 2009
Primary CompletionSep 1, 2010
Study CompletionJul 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 16.7 years ago
Interventions
CRT-D and LV lead (Quartet™ lead and Promote Q® device system)device
Promote Q CRT-D and Quartet LV lead